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Many body surfaces harbor organ-specific gd T cell
compartments that contribute to tissue integrity.
Thus, murine dendritic epidermal T cells (DETCs)
uniquely expressing T cell receptor (TCR)-Vg5 chains
protect from cutaneous carcinogens. The DETC
repertoire is shaped by Skint1, a butyrophilin-like
(Btnl) gene expressed specifically by thymic epithelial
cells and suprabasal keratinocytes. However, the
generality of this mechanism has remained opaque,
since neither Skint1 nor DETCs are evolutionarily
conserved. Here, Btnl1 expressed by murine entero-
cytes is shown to shape the local TCR-Vg7+ gd
compartment. Uninfluenced bymicrobial or food anti-
gens, this activity evokes thedevelopmental selection
of TCRab+ repertoires. Indeed, Btnl1 and Btnl6 jointly
induce TCR-dependent responses specifically in in-
testinal Vg7+ cells. Likewise, humangut epithelial cells
express BTNL3 and BTNL8 that jointly induce selec-
tive TCR-dependent responses of human colonic
Vg4+ cells. Hence, a conserved mechanism emerges
whereby epithelia use organ-specific BTNL/Btnl
genes to shape local T cell compartments.
INTRODUCTION
The specialized differentiation of body surface epithelia is most
commonly viewed from the perspective of organ-specific phys-
iological functions, such as nutrient absorption in the gut and
prevention of trans-epidermal water loss. Likewise, differenti-
ated epithelia provide physical and chemical barriers to patho-
gens and toxins (Janeway et al., 2001). However, it is now appre-
ciated that body surfaces at steady state comprise diverse cell
types, including many immune cells (Vantourout and Hayday,
2013). Among these, intraepithelial lymphocytes (IELs) express-
ing ab T cell receptors (TCRs) can mount rapid recall responsesCell 167, 203–218, Septe
This is an open access article undto pathogens, while other IELs, commonly expressing gd TCRs,
contribute to the maintenance of body surface integrity that is
key tometazoan viability. Thus,murine gut gd T cells regulate en-
terocyte differentiation and turnover (Komano et al., 1995) and
limit inflammatory damage (Hayday and Tigelaar, 2003; Hayday,
2000; Roberts et al., 1996), while TCRgd+ dendritic epidermal
T cells (DETCs) (Kuziel et al., 1987; Stingl et al., 1987a) limit
inflammation, promote wound resolution, and increase cuta-
neous resistance to carcinogens (Girardi et al., 2001, 2002;
Jameson et al., 2002; Strid et al., 2008). Moreover, the skin
and gut of jawless fish harbor cells similar to TCRgd+ IELs,
arguing that such compartments fulfil critical, evolutionarily
conserved roles (Hirano et al., 2013).
In mice, large IEL compartments are defined by gd TCRs that
match particular anatomical sites: Vg5 in skin, Vg7 in gut, and
Vg6 in the uterus (Allison and Havran, 1991; Asarnow et al.,
1988; Guy-Grand et al., 2013; Itohara et al., 1990; Kyes et al.,
1989; Lefrancois and Goodman, 1989; Stingl et al., 1987a,
1987b; Vantourout and Hayday, 2013). Conceivably, these align-
ments are determined by organ-specific products of epithelial
differentiation, particularly since TCRgd+ IELs are largely unaf-
fected by major histocompatibility complex (MHC) antigens
that shape ab T cell repertoires. Likewise, whereas some gd
TCRs bind CD1 and MR1, genetic studies have largely excluded
these MHC-related molecules from the selection of murine gd
cell repertoires (Bigby et al., 1993; Correa et al., 1992; Hayday
and Vantourout, 2013; Kuziel et al., 1987; Lefrancois et al.,
1990; Pereira et al., 1997).
One insight into how epithelia might shape local IEL reper-
toires was provided for the skin by the discovery of Skint1, the
founding member of a novel multi-gene family specifically ex-
pressed by thymic epithelial cells and keratinocytes. Skint1
drives the selective maturation of Vg5+ DETC progenitors, and
DETCs are >90% ablated in Skint1 mutant mice, while all other
T cells are unaffected (Barbee et al., 2011; Boyden et al., 2008;
Turchinovich and Hayday, 2011). However, the generality of
this mechanism for IEL selection was questioned, since neither
DETCs nor Skint1 is broadly conserved and because Skint genes
are only expressed in skin and thymus (Boyden et al., 2008).mber 22, 2016 ª 2016 The Authors. Published by Elsevier Inc. 203
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Selective Maturation and Expansion of Intestinal IELs in Mice
(A) Gating strategy for small intestinal (SI) Vg7+ IELs in 12-week-old C57Bl/6 mice (nR 12). Bottom right: Vg7+ IEL representation over time (n = 5, week 20–36;
nR 12, other time points).
(B) IEL composition assessed by confocal microscopy of proximal SI whole mounts (n = 3) and corresponding quantification (right).
(C) Top: surface phenotypes of Vg7+, Vg7 (CD3+TCRbVg7) and ab IELs from 21- to 40-day-old mice (nR 8). Bottom: gene expression in Vg7+ versus Vg7
IELs (n = 3).
(D) Surface phenotypes of Vg7+ IELs at days 14–17 versus days 21–40 (nR 7).
(E) Top: surface phenotype of Vg7+ IELs at day 14 and day 28 (CD122 median fluorescence intensity [MFI]-colored text). Bottom: surface phenotype of
CD122HIThy1Vg7+ versus CD122LOThy1+Vg7+ IELs at days 14–17 (nR 7).
(F) Heatmap of genes differentially expressed between Vg7+CD122HI and Vg7+CD122LO IELs from day 14–17 mice and between Skint1-selected and non-
selected Vg5+ DETC progenitors (n = 4).
(legend continued on next page)
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This notwithstanding, Skint genes sit within the Btnl family
comprising six rodent and five human genes. Their poorly under-
stood gene products are structurally similar to CD80 and PDL1
co-stimulatory and inhibitory molecules, which are themselves
considered to be evolutionarily related to the MHC (Abeler-
Do¨rner et al., 2012; Afrache et al., 2012; Barbee et al., 2011; Rho-
des et al., 2001; Salim et al., 2016; Stammers et al., 2000). By
definition, Btnl/BTNL genes are structurally similar to butyrophi-
lin (Btn/BTN) genes, of which mice have two and humans six.
Butyrophilin genes derive their name (‘‘butter-loving’’) from the
founding member, Btn1a1/BTN1A1, that encodes a milk fat
micelle-associated protein (Franke et al., 1981). However, this
function appears atypical in contrast to the recent implication,
albeit largely imprecise, of several BTN/Btn/BTNL/Btnl gene
products in immune regulation (Rhodes et al., 2016). Provoca-
tively, human BTN3A1 facilitates peripheral blood gd T cell re-
sponses to low-molecular-mass microbial and endogenous me-
tabolites (so-called phosphoantigens), although it is not known
whether this is mediated by direct TCR-BTN3A1 binding (Adams
et al., 2015; Harly et al., 2012; Palakodeti et al., 2012; Vavassori
et al., 2013; Wang et al., 2013).
To explore whether Btnl genes might mediate epithelial regu-
lation of local gd T cells, we considered the mouse gut, the major
site of Btnl1, Btnl4, and Btnl6 expression (Bas et al., 2011). Here,
we identify a time window early in the development of young
mice in which Btnl1 expressed by post-mitotic, small intestinal
villus epithelial cells critically and selectively promotes the matu-
ration and expansion of Vg7+ T cells, thereby shaping the IEL
compartment. Requiring neither microbial nor food antigens,
this process evokes Skint1-mediated DETC selection and ab
T cell selection by the MHC. Indeed, we show that intestinal
epithelial cells expressing Btnl1 jointly with Btnl6 can induce
TCR-dependent stimulation uniquely of intestinal Vg7+ T cells.
gd cells have often been viewed as species specific with few
features conserved between mouse and humans (Kazen and
Adams, 2011; Vantourout and Hayday, 2013). However, it is
increasingly clear that human tissues too harbor large gd cell
compartments with TCRs distinct from those in peripheral blood
(Landau et al., 1995; Vantourout and Hayday, 2013; our unpub-
lished data). Furthermore, a large bioinformatics study of thou-
sands of cancer patients presenting with a broad range of carci-
nomas established that the best correlate of overall survival was
a tumor-associated gd T cell gene signature (Gentles et al.,
2015). Hence, there is a pressing need to define how human
epithelia interact with tissue-resident gd T cells.
Addressing this, we provide a refined description of human
colonic gd cells and show that a signature subset expressing
TCRVg4 is specifically regulated by human BTNL3 and BTNL8
expressed by human gut epithelium. Hence, the specialized dif-
ferentiation of intestinal epithelial cells in mice and in humans in-
cludes the expression at steady state of site-specific regulators
of local T cell compartments.(G) Ki67 expression in Vg7+ versus Vg7 IELs directly ex vivo (n = 4, day 19; n =
Data are representative of one (C, qPCR, B and F) or three or more (C, cytometry, D
three or more (E), more than ten (G), and >20 (A) independent experiments. D, d
All error bars represent mean ± SD. See also Figure S1.RESULTS
Intestinal Epithelial T Cell Selection
By flow cytometry of cells recovered from epithelium, and by
confocal visualization of epithelial whole mounts, we found
that the signature murine small intestinal Vg7+ IEL compart-
ment largely took shape at 2–3 weeks of age and remained sta-
ble for at least 9 months thereafter (Figures 1A and 1B). At day
21, Vg7+ cells mostly phenocopied mature Skint1-selected
DETCs, expressing uniformly high levels of CD122 (the IL-2R/
IL-15Rb chain), TIGIT (an inhibitory co-receptor), and the TCR
(detected with anti-CD3 antibodies) and low levels of RNA for
Rorgc and Sox13, two transcription factors contributing to gd
T cell differentiation (Vantourout and Hayday, 2013) (Figure 1C).
Vg7 IELs (mostly Vg1 or Vg4) did not show this phenotype,
and whereas both Vg7+ and Vg7 IEL subsets were mostly
CD45RBhi, CD44+, and CCR9+, Vg7+ IELs were distinct in being
Lag3+, Thy1, CD69+, CD5, and CD8aa+ (Figures 1C and
S1A).
Prior to day 21, however, Vg7+ IELs phenocopied Vg7 IELs
of adult mice. Thus, by sequential gating and radar plots of sur-
face protein co-expression, one could clearly distinguish mature
Vg7+ IELs (CD122hi[MFI > 500], Thy1, TIGIT+, Lag3+, CD8aa+,
CD5, CD24, TCRhi) from putative Vg7+ IEL progenitors
(CD122lo[MFI < 200], Thy1+, TIGIT, Lag3, CD8aa, CD5+,
CD24+, TCRlo) (Figures 1D, 1E, and S1B), with the latter also phe-
nocopying DETC progenitors prior to Skint1 selection (Turchino-
vich and Hayday, 2011).
To further compare IELs with their putative progenitors,
CD122hi Vg7+ and CD122lo Vg7+ IELs were purified from the
same day 14–17 mice on four independent occasions and as-
sessed by RNA sequencing (RNA-seq) (Figure S1C). Consistent
with their distinct phenotypes, the cells showed significantly
different expression of many genes for cell surface proteins (Fig-
ure S1C). Furthermore, many genes up- (e.g., Tnfrsf9 [4-1BB/
CD137], Xcl1 [lymphotactin], Nasp) or downregulated (e.g.,
sox13, Bcl11b, Cx3cr1) in CD122hi versus CD122lo Vg7+ cells
were likewise regulated by Skint1 selection of DETC progenitors
(Figures 1F and S1C).
Additionally, CD122hi Vg7+ cells were enriched in cell-cycle
genes, consistent with which 100% of Vg7+ IELs at day
21–24 were Ki67+ (i.e., outside of G0), compared to <40% of
Vg7 cells (p < 0.0001) (Figure 1G). Likewise, Vg7+ IELs at day
28 phenocopied rapidly dividing thymocytes in that10% incor-
porated ethynyldeoxyuridine (EdU) (a labeled nucleotide) during
a 3-hr pulse, compared to only 4% of Vg7 IELs (Figure S1D).
In sum, these data are consistent with the gut supporting the
selective maturation and expansion of CD122hi, Thy1, TIGIT+,
Lag3+, CD8aa+, CD5, CD24, TCRhi Vg7+ cells that by weeks
3–4 dominate the gd IEL compartment. After week 5, the fraction
of cycling (Ki67+) Vg7+ IELs at steady state declined to levels
comparable to Vg7 IELs (Figure 1G).8–27, other time points).
and E, top) independent experiments. Some panels present data pooled from
ay; W, week.
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A Gut Epithelial Selecting Element
Because Skint1 selects for signature Vg5+ DETC progenitors in
the thymus, DETCs are absent from athymic NU/NU mice. By
contrast, intestinal IELs were present in NU/NU, and although
there was some decrease in numbers (average of 1.3 3 106
cells compared to >2.03 106 cells in euthymic mice; see below),
the compartment was again dominated by CD122hi Vg7+ IELs.
Moreover, 25% of Vg7+ IELs in NU/NU and in euthymic mice
reacted with antibody GL2 that detects Vd4 (TRDV2-2 encoded)
chains. Consistent with this, TRDV2-2 sequences accounted for
25% of TCRd chain RNAs expressed by purified Vg7+ IELs
(Figures 2A and S2A). In sum, the shaping of the gut Vg7+ IEL
compartment did not require a thymus.
Consistent with this, Vg7+ thymocytes were rare, comprising
<10% of TCRgd+ cells in fetal and post-natal thymi across
the first 8 weeks of life, the peak period of thymus function in
mice (Figure S2B). Furthermore, most Vg7+ thymocytes were
CD45RBlo, Thy1+, CD5hi, CD122lo, TCRlo, and CD8aa,
thus offering no evidence for intrathymic maturation (Figures
S2C–S2E). Likewise, neither lymph nodes nor Peyer’s patches
(PP) were required to shape the IEL compartment, since normal
numbers of Vg7+ and Vg7GL2+ IELs with signature phenotypes
were present in aly/aly (alymphoplasia) mice (Shinkura et al.,
1999) that following surgery were confirmed to lack PP and pe-
ripheral and mesenteric lymph nodes (MLNs) (Figure S2F).
As intestinal driver(s) of IEL maturation in weanling mice, mi-
crobial and/or food antigens were logical candidates. However,
C57Bl/6 mice bred into and maintained in a germ-free environ-
ment and/or on elemental, protein-antigen-free diet displayed
Vg7+ and Vg7GL2+ IEL compartments comparable to conven-
tionally housed counterparts (Figure 2B). The Vg7+ IELs were
uniformly TCRhi, CD122hi, and absolute numbers were some-
what increased, partially compensating for the decline of TCRab
IELs in germ-free and protein-antigen-free mice (Figure 2B).
Thus, the local T cell compartment is most likely shaped by an
endogenous intestinal element(s).
In seeking that element(s), we focused on three genes, Btnl1,
Btnl4, and Btnl6, that are closely related to Skint1 (Abeler-Do¨rner
et al., 2012; Afrache et al., 2012; Bas et al., 2011). Btnl4 was ex-
pressed at low levels in proximal small intestine, commencing in
the fetus. Btnl1 and Btnl6 RNAs were detected at day 6 post-
partum, andBtnl1 levels further increasedat aroundday14before
the expression of all three Btnl genes stabilized (Figure 2C).
Expression was in post-mitotic villus enterocytes that are inter-
spersed with IELs and was essentially absent from villus crypts
that house replicatingepithelial cell progenitors and lack IELs (Fig-
ures 2D, 2E, and S2G). Btnl1 expression peaked in proximal and
medial small intestine (Figure S2H), where its expression was
>107-fold higher than in the thymus (FigureS2I). These expression
patternscould permitBtnl1,Btnl4, and/orBtnl6 to act locally upon
Vg7+ IELs in weanling mice. To investigate this possibility, we ob-
tained three independent strains of Btnl1/ mice and one of
Btnl4/ mice, each generated by targeted mutagenesis of em-
bryonic stem cells (ESCs), and a strain with an internally deleted
Btnl1 locus generated by clustered regularly interspaced short
palindromic repeats (CRISPR)-Cas9 in mouse eggs (Figure S2J).
The strains were confirmed as gene knockouts by DNA analysis
and loss of respective Btnl RNAs (Figures 2E and S2I–S2K).206 Cell 167, 203–218, September 22, 2016Btnl1 Shapes the Intestinal IEL Compartment
The four Btnl1/ strains each displayed major, highly selective
losses of Vg7+ IELs, assessed by flow cytometry or confocal
microscopy (Figures 3A, 3B, and S3A). Vg7+ IEL numbers
were depleted by 90%, with Vg7GL2+ cells almost ablated.
Because Vg7 IEL numbers barely increased, the percentage
representation of Vg7+ cells among gd IELs was reduced
only by 3-fold relative to wild-type (WT) mice, but this was
set against a background of dramatically reduced gd IEL
numbers (Figures 3A and S3A). By contrast, TCRb+CD8aa+
IEL numbers increased significantly in Btnl1/ mice (Figures
3A and 3B).
The specificity of Btnl1 for Vg7+ IELs was emphasized by
comprehensive immune phenotyping of Btnl1/, WT, and
Btnl1+/ mice that showed comparable splenic or MLN immune
cell subsets (including gd cell repertoires) and comparable
representation and phenotypes of Vg7+ thymocytes from day 4
to week 8 (Figures S3B–S3E). Consistent with its expression
pattern, Btnl1 acted extrathymically; thus, Btnl1 deficiency
crossed onto NU/NU mice reduced the average number of
Vg7+ IELs by90%, with almost total loss of Vg7GL2+ IELs (Fig-
ure 3C). Since NU/NU mice lack most ab T cells, this result ex-
cludes the formal albeit unlikely possibility that Vg7+ IEL losses
in euthymic Btnl1/ mice indirectly reflected expanded TCR
ab IELs. The specificity of Vg7+ IELs for Btnl1 was emphasized
by the fact that Btnl4/ mice displayed no overt defects in
any major IEL subset (Figure 3D).
Btnl1 Selects Vg7+ IEL In Trans
To determine how and when Btnl1 impacts IELs, we examined
residual Vg7+ and Vg7GL2+ IELs in Btnl1/ mice. Relative to
those in WT mice, significantly fewer Vg7+ IELs incorporated
EdU at D28 [p < 0.0001] or expressed Ki67, and this did not
change until W7 when most Vg7+ IELs in WT mice moved out
of cycling (Figures 4A and S4A). Thus, there was no selective
expansion of Vg7+ IELs in Btnl1/ mice. Similarly, although
their TCR levels were high, many residual Vg7+ and Vg7GL2+
IELs in week 3–5 Btnl1/ mice were CD122lo, Thy1+, TIGIT,
Lag3, CD8aa, CD5+, CD24+, thereby phenocopying imma-
ture Vg7+ IELs of day 14–17 WT mice (Figures 4B, 4C, and
S4B).
To demonstrate that Btnl1 exerts its selective impact on Vg7+
T cells in trans, we established conditions in which the Vg7+ and
Vg7GL2+ IEL compartments of week 3–5 WT mice were recon-
stituted within 5 weeks of donor bone marrow (BM) transfer
to irradiated 8- to 10-week, gd T cell-deficient TCRd/ mice
(Figure S4C). BM from either WT orBtnl1/mice proved equally
effective at IEL reconstitution (Figure 4D). Not surprisingly, WT
BM reconstitution of Vg7+ IELs in irradiated, congenic T cell-suf-
ficient CD45.2+ WT recipients was less effective than it was in
TCRd/ hosts (compare plots, top left in Figures 4D and 4E),
but nonetheless, reconstitution of Btnl1/ hosts was much
less effective, and the few Vg7+ and Vg7GL2+ IELs that devel-
oped in Btnl1/ recipients phenocopied residual Vg7+ cells in
Btnl1/ mice and immature IELs in day 14–17 WT mice (Fig-
ure 4E). Complementing these findings, purified IELs from
4-week-old mice could reconstitute Vg7+ IELs in recipient
TCRd/ mice, albeit very inefficiently, and this too was greatly
Figure 2. A Gut IEL Selecting Element
(A) Left: IEL composition in WT versus NU/NU mice; antibody GL2 detects TRDV2-2-encoded Vd4 chain. Right: surface CD122 expression on NU/NU Vg7+ IELs
(nR 12).
(B) IEL composition (top), enumeration (bottom left), and CD122 expression (bottom right) in germ-free (GF), food antigen-free (FAF), or GF-FAF C57Bl/6 mice at
weeks 9–13 (nR 4).
(C) qRT-PCR of denoted genes.
(D) Histological analysis of Btnl1 RNA (middle: RNAScope) and 3-hr BrdU incorporation in vivo (bottom) in paraffin-embedded SI gut rolls (nR 3).
(E) RNAScope of Btnl1, Btnl4, and Btnl6 in WT versus Btnl1/ and Btnl4/ mice.
Data are representative of two (B), two or more (D and E), or three or more (A) independent experiments. In (C), data are pooled from two independent
experiments.
All error bars represent mean ± SD. See also Figure S2.impaired in Btnl1/TCRd/ hosts (Figure S4D). Thus, Btnl1
acts in non-hematopoietic cells to support the selective expan-
sion and maturation of Vg7+ IEL.To attempt to restore IEL selection, we renderedBtnl1/mice
transgenic for Btnl1 expressed from a doxycycline (Dox)-induc-
ible promoter (Figures S5A and S5B) and crossed them ontoCell 167, 203–218, September 22, 2016 207
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Btnl1/ mice, into which was introduced a Dox-responsive
trans-activator (rtTA) regulated by the ubiquitously expressed
Rosa26 promoter. As reported, adding low-dose Dox to drinking
water had little overt impact on the gut over a several-week
period (Roth et al., 2009). Therefore, this system offered ameans
to globally induce Btnl1 de novo in Btnl1/ bitransgenic (BiTg)
mice that inherited both rtTA and the inducible Btnl1 transgene.
Conversely, BiTg mice administered sugar water and Dox-
treated single-transgenic (SiTg) Btnl1/ mice (that inherited
only the Btnl1 transgene) served as controls. Btnl1 induction
in mice of appropriate genotypes was validated by qPCR
(Figure S5C).
When several W11 Btnl1/ BiTg mice were treated in this
way, the representation of Vg7+ and Vg7+GL2+ IELs was un-
changed relative to littermate controls, but the percentage of
Vg7+ IELs that were CD122hi increased greatly, and most ex-
pressed Ki67. This was not true for Vg7 or TCRb+ IELs (Figures
S5D–S5F). Thus, Btnl1 induction de novo in adult mice partially
phenocopied Vg7+ IEL-specific maturation in early life but did
not reconstitute Vg7+ IEL numbers. Global Btnl1 induction also
did not drive ectopic Vg7+ cell maturation in any other tissues
(unpublished data).
A Temporal Window for Epithelial Btnl Activity
In further experiments, we restricted Btnl1 induction to mature
enterocytes by generating Btnl1/ mice transgenic for rtTA
expressed from the villin promoter. Within 1–2 weeks of Dox-
treatment of several W11 BiTg Btnl1/ mice, most Vg7+ IELs
had become Lag3hi, Thy1, and CD122hi, of which the majority
were also Ki67+ (Figures 5A and 5B). Again, this phenotypic
transition was Vg7+ IEL specific, albeit there were sometimes
Btnl1-independent increases in Ki67+ TCRb+ IELs in sugar-wa-
ter-treatedmice. (Figure 5B).Oncemore, the numbers and repre-
sentation of Vg7+ IELswere unchanged, even inmice retained on
Dox for 3–4 weeks (Figure 5C). This establishes that Btnl1 can
effect phenotypic conversion of immature Vg7+ IELs rather than
merely promote a selective outgrowth of mature Vg7+ cells.
However, there was significantly increased representation of
Vg7+ and Vg7GL2+ IEL when Btnl1 expression was induced in
Btnl1/ mice in early-life by commencing Dox-treatment of
nursing females at D7 or of weanlings at D21 and then main-
taining treatment for 2-5 weeks (Figure 5D). Moreover, the
expanded Vg7+ cells phenocopied IEL of W4-5 WT mice, and
were significantly different from the IEL of Dox-treated SiTg
mice and Btnl1/ mice (Figure 5E). Thus, acute expression of
Btnl1 purely in the gut epithelium induces the selective pheno-
typic maturation and expansion of Vg7+ IEL, but these effects
are separable, with selective expansion mostly confined to a
developmental window within the first five weeks of life.Figure 3. Gut IEL Composition Depends on Btnl1
(A) Left: enumeration of IEL subsets from week 6–15 WT and Btnl1/ mice by
Btnl1/ lines and controls (nR 6).
(B) Confocal microscopy of proximal SI whole mounts from week 10 WT and Btn
(C) Vg7+ IEL representation (left) and enumeration (right) of WT (2.6 m ± 630,000
(D) Representation (left) and enumeration (right) of IEL subsets fromWT, Btnl1/,
independent (A) experiments.
All error bars represent mean ± SD. See also Figure S3.Epithelial Btnl1 and Btnl6 Regulate Vg7 Cells
Given that acuteBtnl1 expression drives the selectivematuration
of Vg7+ IELs in vivo, we tested whether Btnl1 might show spec-
ificity for Vg7+ IEL ex vivo. Since primary intestinal epithelial
cells reportedly harbor Btnl1 in a complex with Btnl6 (Lebrero-
Ferna´ndez et al., 2016), we sought evidence for heterotypic inter-
actions of Btnl proteins. Indeed, cell surface expression of Btnl1
on Btnl1-transfected MODE-K cells (an established intestinal
epithelial cell line in which endogenous Btnl genes are negligibly
expressed) was greatly enhanced by co-transfection with Btnl4
or Btnl6 (Figure S6A). Likewise, surface Btnl6 expression was
greatly enhanced by Btnl1, but there was no evidence for collab-
oration between Btnl6 and Btnl4 (Figure S6A). Given the speci-
ficity of Btnl6 for Btnl1, and given that Btnl4/ mice showed
no IEL phenotype, we focused on Btnl1 and Btnl6.
MODE-K cells stably transduced with Btnl1 (L1), Btnl6 (L6),
Btnl1 plus Btnl6 (L1+6), or empty vector (EV) were co-cultured
with freshly explanted IELs that were then assayed for CD25
(IL-2Ra chain) upregulation, which is among the most robust
readouts of TCR stimulation for systemic T cells (Depper et al.,
1984; Kim and Leonard, 2002). Whereas mixed TCRab+ and
TCRgd+ IELs showed minor CD25 upregulation upon co-culture
with EV, L1, or L6 cells, IELs exposed to L1+6 cells showed high-
ly significant CD25 upregulation, wholly attributable to 20% of
Vg7+ cells (both Vg7GL2+ and Vg7GL2 cells) (Figure 6A). Signif-
icant CD25 upregulation was first evident within 4–6 hr, as is true
for systemic TCR stimulation (Depper et al., 1984; Kim and Leo-
nard, 2002) (Figure S6B).
When L1+6 cells were co-cultured with primary IELs from
Nur77.gfp mice in which GFP is upregulated by nuclear factor
of activated T cells (NFAT) activation downstream of TCR
signaling (Moran et al., 2011), essentially all IELs that upregu-
lated CD25 were GFP+ (Figure 6B). This phenotype was not
shown by Vg7 or TCRab+ IELs in the same co-cultures (Fig-
ure 6B). IEL upregulating CD25 also downregulated CD122, an
additional symptom of systemic TCR stimulation (Yu and Malek,
2001) (Figure S6C). Thus, CD25+GFP+CD122 cells arose
uniquely among Vg7+ IEL co-culturedwith L1+6 cells (Figure 6C).
Moreover, CD25 upregulation was accompanied by slight but
significant TCR downregulation, another rapid response to
TCR stimulation (San Jose et al., 2000) (Figure 6D). Btnl1+Btnl6
acted directly on Vg7+ IEL, since CD25 was upregulated on cells
that had been purified by flow cytometry prior to L1+6 cell co-
culture (Figure S6D). (Note that background CD25 expression
was increased by TCR-dependent sorting, but this did not
obscure the result.)
When IEL were separated from L1+6 cells by transwells, CD25
upregulation was abrogated and could not be secondarily trans-
activated by IELs that were in contact with L1+6 cells, e.g., viaflow cytometry. Right: representative data from three independently derived
l1/ mice (n = 3).
), NU/NU (0.9 m ± 600,000) and Btnl1/ NU/NU mice (0.1 m ± 120,000).
and Btnl4/mice. Some panels include data pooled from two (C and D) or six
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Figure 4. Btnl1 Drives Selective Expansion and Maturation of Gut IEL
(A) 3 hr EdU incorporation in vivo in gd IEL subsets and thymocytes from week 4 WT versus Btnl1/mice (nR 9). (B) Surface phenotypes of Vg7+ and Vg7GL2+
IELs from week 3–5 WT and Btnl1/ mice (nR 8).
(C) Top: Thy1 and CD122 expression by Vg7+ IEL from day 35Btnl1/mice (n = 8). Bottom: surface phenotypes of CD122HIThy1 and CD122LOThy1+ Vg7+ IELs
from week 4–6 Btnl1/ mice (nR 4). W, week.
(D and E) IEL reconstitution and CD122 profiles in (D) irradiated TCRd/ mice 9–10 weeks post-BM transfers from indicated donors (nR 7) and (E) irradiated
CD45.2+ WT or Btnl1/ mice 4–5 weeks post-BM transfers from CD45.1+ C57Bl/6 mice (n = 7).
Data are representative of two (D and E) or three or more (C, top) independent experiments. Panels (A) and (C) (bottom) present data pooled from three or more
experiments.
All error bars represent mean ± SD. See also Figure S4.secreted cytokines (Figure 6E; compare blue with yellow bars in
bottom panel). CD25 upregulation by IELs in contact with L1+6
cells showed dose-dependent inhibition by PP2, which inhibits
signaling by src-family kinases, such as Lck and Fyn, but was
not inhibited by PP3, an established control for PP2 specificity
(Figure S6E).
Just as residual Vg7+ IEL in Btnl1/mice responded to acute
transgenic Btnl1 induction in vivo, they were comparable to WT
Vg7+ IELs in responding to Btnl1 plus Btnl6 ex vivo (Figure 6F).210 Cell 167, 203–218, September 22, 2016Interestingly in the same experiments, WT Vg7+ IELs showed
relatively poor responses to anti-CD3, phenocopying the attenu-
ated responsiveness imposed on Vg5+ DETC progenitors by
Skint1 (Wencker et al., 2014), whereas Vg7+ IELs from Btnl1/
mice, and TCRab+ and Vg7 IELs from WT mice, none of which
subsets had experienced prior Btnl1 selection in vivo, all showed
strong responses to anti-CD3 (Figures 6F and 6G).
Finally, the supernatants of IEL co-cultures with L1+6 cells
showed small but significant increases in interferon-g (IFN-g),
Figure 5. Villin-Specific Btnl1 Induction Rescues Vg7+ IEL In Vivo
(A–D)Week 7–13 (adult) or day 7–21 (pups) mice of indicated genotypes on aBtnl1/ backgroundwere administered Dox (1mg/ml, 2% sucrose) or control water
(2% sucrose) for times indicated, and IELs were analyzed by flow cytometry. nR 5 (A and B); nR 6 (C and D).
(E) Comparative cell-surface phenotypes of Vg7+ IELs from week 4–5 WT mice and animals indicated (n = 4–8).
(A) is representative of two or more independent experiments; (B)–(E) present data pooled from three or more experiments. Statistical significance in (C) was
determined using the Holm-Sidak method.
All error bars represent mean ± SD. See also Figure S5.CCL4, and granulocyte macrophage colony-stimulating factor
(GM-CSF) among 36 cytokines tested (Figure 6H). These are
typical IEL effectors, and although it was technically challenging
to attribute production to Vg7+ IELs, such increases were notseen in supernatants of L1+6 cells cultured with IELs from
TCRd/mice. (Note the higher background cytokine expression
in TCRd/ mice may reflect spontaneous inflammation often
associated with gd deficiency; Hayday and Tigelaar, 2003.) InCell 167, 203–218, September 22, 2016 211
(legend on next page)
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sum, a range of metrics attested to a highly specific and direct
interaction ex vivo of Vg7+ IELs with Btnl1 and Btnl6 co-ex-
pressed on gut epithelial cells.
Signature Human Intestinal gd T Cells
Because of limited tissue access, human gut T cells are under-
studied. Nonetheless, there are gut-associated gd cells whose
TCR usage differs markedly from Vg9+Vd2+ cells that dominate
the peripheral blood (Landau et al., 1995). To better characterize
such cells, we submitted biopsy specimens from healthy
ascending colon to a modified version of a protocol used to
isolate human skin T cells (Clark et al., 2006). For 16 of 17 donors,
the gd cells were enriched in Vd1+ cells, although Vd1Vd2 cells
were also present; hence, the term ‘‘Vd2’’ is used to distinguish
tissue-associated gd cells from Vd2+ cells that could also be
recovered from most gut samples, albeit in highly variable
numbers (Figure 7A).
Of six functional human Vg chain genes (Vg2, 3, 4, 5, 8, and 9)
(Arden et al., 1995), Vg4was reported to be the signature chain of
intestinal Vd2 cells (Landau et al., 1995). Indeed, for up to ten
donors examined, most intestinal Vd2 cells reacted with a
Vg2/3/4-specific antibody, but not a Vg5/3-specific antibody
(blue and red bars, Figure 7B; Table S1A), and TCR deep
sequencing showed that Vg4 sequences far outnumbered Vg2
sequences (Figure S7A). Thus, despite individual variation,
most gut gd T cell compartments included a substantial
Vg4+Vd2 subset, while some donors also displayed relatively
high representation of Vg8+Vd1+ cells (Figure 7B; Table S1A).
BTNL3 and BTNL8 Regulate Human Vg4+ Cells
There is no human equivalent of the Btnl2-proximal amplicon on
mouse chromosome 17 that encodes Btnl1, Btnl4, and Btnl6
(Abeler-Do¨rner et al., 2012; Afrache et al., 2012). However, adja-
cent to human BTNL9 is an amplicon that encodes BTNL3 and
BTNL8 whose expression is highly enriched in gut, particularly
EpCAM+ epithelial cells (Figures S7B–S7D). Interestingly, akin
to the behavior of Btnl1 and Btnl6 described above, neither
BTNL3 nor BTNL8 protein was efficiently expressed on cells
transfected with their respective genes, unless both were co-ex-
pressed (Figure S7E, green line, top right histogram; blue line,
bottom right histogram). Conversely, BTNL8S (a splice variant
of BTNL8) failed to rescue surface BTNL3 expression (Fig-
ure S7E, red line, top right histogram).
Whereaswe could not test for a developmental dependence of
human gut gd cells on BTNL3 and BTNL8, we could assess
whether BTNL3 and BTNL8 phenocopied Btnl1 and Btnl6 byFigure 6. Gut Vg7+ IELs Respond to Btnl Proteins
(A) Left: surface CD25 expression of designated IEL subsets after 12-hr co-culture
Btnl6 (L6), or Btnl1 plus Btnl6 (L1+6). Right: fold increase in CD25+ cells as perc
(B) GFP and CD25 expression by designated IELs from Nur77.gfp mice ex vivo o
(C) Percentage of Vg7+ IELs from Nur77.gfp mice that were CD25+GFP+CD122
(D) CD3 expression in Vg7+CD25+ or Vg7+CD25 IELs after 12-hr co-culture of t
(E) Surface CD25 expression as percentage of Vg7+ IELs after indicated transwe
(F) Surface CD25 expression on Vg7+ IELs from WT and Btnl1/ mice after indi
(G) Surface CD25 expression by designated IEL subsets after incubation with an
(H) Cytokine concentrations assessed by luminex in supernatants after 48 hr of c
Data are representative of one (H), two (B) or more than three (A, D, and E) indepen
three (A, F, and G) independent experiments. All error bars represent mean ± SDspecifically activating signature gut gd cells in a TCR-dependent
fashion. Thus, we established short-term co-cultures of primary-
gut-derived lymphocytes with HEK293T cells transduced with
BTNL3 (L3), BTNL8 (L8), BTNL3 and BTNL8 (L3+8), or EV (Fig-
ure S7F). For the representative donor shown, some of the
discrete subsets of Vd1 and Vd1+ gd cells that were apparent
in T cell co-cultures with control (EV, L3, and L8) cells showed
marked TCR downregulation when co-cultured with L3+8 cells
(red arrows Figure 7C). Emphasizing specificity, TCR downregu-
lation occurred in response to L3+8 cells in 21 of 23 donors but
was never seen in co-cultures with L3 or L8 cells, and was never
shown by intestinal Vd2+ or TCRab+ cells, even in the same cul-
tures as responding Vd2 cells (Figure 7D). Although higher
baseline CD25 expression reduced the sensitivity of this assay
for human versus mouse gut T cell activation ex vivo, L3+8
cells induced significant CD25 upregulation vis-a-vis gut
T cells co-cultured with control cells (Figure 7E), and CD25 upre-
gulation was most evident on cells with downregulated TCRs
(Figure S7G).
Not all Vd2 cells responded to L3+8 (Figure 7C). Thus, we
considered that TCRg chainsmight determine BTNL responsive-
ness, as is true in mice. Indeed, human Vd2 populations that
downregulated TCRs in co-cultures with L3+8 cells were de-
tected by the Vg2/3/4-specific antibody, but not by antibodies
to Vg8, Vg5/3, or Vg9 (Figures 7F and 7G). Moreover, produc-
tively rearranged Vg4 genes were prevalent when L3+8-respon-
sive cells with downregulated TCRs were flow cytometry sorted
from one donor (Figure S7H) and their Vg chains amplified
without bias and sequenced (red notation, Table S1B). By
contrast, TCRg transcripts from skin-derived TCRgd+ cells
(G234SK01) were biased toward Vg3 (purple notation Table
S1B). Interestingly, of two donors showing no substantial
response to BTNL3+8, one proved a posteriori to have an atyp-
ical intestinal gd T cell repertoire dominated by Vg8+ cells (Fig-
ure S7I). Likewise, L3+8 cells induced no significant TCR
down-modulation by primary gd+ T cells from skin or blood
among which Vg4+ cells are rare (Figure 7H). Thus, epithelial
BTNL genes regulate human-tissue-resident gd T cells in an or-
gan-specific, TCRg-chain-specific manner.
DISCUSSION
This study shows that the unique composition of the murine in-
testinal intraepithelial T cell compartment arises from a selective
maturation and expansion of Vg7+ T cells driven by Btnl1, and
most likely Btnl6, expressed by differentiated enterocytes.of total IELs with MODE-K cells transduced with empty vector (EV), Btnl1 (L1),
entage of the IEL subset relative to co-culture with MODE-K.EV (n = 21).
r after 12-hr co-culture of total IELs with designated cells (n = 8).
directly ex vivo or after 12-hr co-culture of total IELs with designated cells.
otal IELs with MODE-K.L1+6 (n = 21).
ll co-culture conditions (n = 3).
cated culture conditions (n = 7).
ti-CD3 or control immunoglobulin (Ig) (nR 12).
o-cultures indicated (n = 3).
dent experiments. Some panels present data pooled from two (C) or more than
. See also Figure S6.
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Figure 7. Regulation of Human Gut Vg4+ Cells by BTNL3 and BTNL8
(A and B) Vd (A, n = 17) and Vg (B, n = 6–10) expression by human gut gd cells.
(C) Surface TCRgd/Vd1 expression on human gut lymphocytes after 12-hr co-culture with BTNL3 (L3) or BTNL3 plus BTNL8 (L3+8)-transduced HEK293T cells.
Red arrows denote shifts in TCR staining.
(D) Top: TCRgd/CD3 expression on designated human gut T cells after 12-hr co-culture with denoted HEK293T transductants. Bottom: mean fluorescence
intensities (MFIs) calculated relative to co-culture with HEK293T.EV (nR 22). For two donors, MFIs for Vd2 cells remained unchanged (dots within the ellipse).
(E) Percentage of CD25HI cells among TCRgd+TCRVd2 T cells after co-culture with denoted cells (n = 5). Statistical analysis was performed by paired t test.
(F) Surface Vg2/3/4 and Vd1 expression on Vd2 gd T cells after co-culture with cells denoted.
(G) TCRgd expression on indicated subsets after co-culture with denoted cells.
(H) TCRgd expression on gd cells from peripheral blood mononuclear cells (PBMCs) or skin after co-culture with denoted cells.
All error bars represent mean ± SD. See also Figure S7 and Table S1.Likewise, BTNL3 and BTNL8 co-expressed by human intestinal
epithelial cells selectively regulate gut Vg4+ T cells. Given that
Skint1 expressed by thymic epithelial cells and keratinocytes
selectively regulates intra-epidermal Vg5+ T cells, tissue-specific
Btnl genes may offer a generalizable means by which epithelia214 Cell 167, 203–218, September 22, 2016shape and regulate local gd T cell compartments. This may
reflect an even broader utilization of BTNL/BTN genes in gd
biology, since BTN3A1 is critical to human peripheral blood gd
cell activation (Harly et al., 2012; Palakodeti et al., 2012; Vavas-
sori et al., 2013; Wang et al., 2013).
Btnl1 and Skint1 effect many of the same changes in Vg7+ and
Vg5+ IEL progenitors, respectively. These include upregulation
of the receptor for IL15, a growth factor expressed by epithelial
cells essential for gd IEL maintenance (De Creus et al., 2002;
Lai et al., 2008; Lodolce et al., 1998); suppression of sox13,
rorgc, and bcl11b that are associated with gd cells producing
IL-17, which is not a property of IELs (Jensen et al., 2008; Turch-
inovich and Hayday, 2011); and attenuation of TCR respon-
siveness, consistent with IELs adopting an innate-like, rapidly
responsive, tissue surveillance role (Wencker et al., 2014).
Being members of the B7 superfamily, Btnl/BTNL/Skint gene
products may act as co-stimulators for IEL receptors yet to be
identified. In this case, they will be the first co-stimulators spe-
cific for cells with particular TCRs; e.g., Vg7+, but not Vg7,
IELs frommouse gut; and Vg4+, but not Vg8+, T cells from human
gut. Alternatively, their exquisite specificities may reflect interac-
tions of Btnl/BTNL/Skint with cognate TCRs, possibly via unique
Vg-CDR1/2 regions. Likewise, human BTN3A1 appears to
mediate its effects via the Vg9Vd2 TCR, although there are no
clear direct binding data. This may reflect a highly complex inter-
action that includes critical co-factors. Of note, BTNL3, BTNL8,
Btnl1, and Btnl6 each contain B30.2 domains related to the
phosphoantigen-binding domain of BTN3A1, raising the possi-
bility that low-molecular-weight metabolite(s) might have a
broad role in gd cell regulation by Btnl/BTNL genes (Adams
et al., 2015). A requirement for co-factors might also explain
the developmental time window during which Btnl1 could drive
the maturation and expansion of Vg7+ IELs.
Peptide-MHC complexes have different impacts on ab T-line-
age cells, including positive and negative selection of thymo-
cytes, T-regulatory cell differentiation, and activation or anergy
of mature peripheral T cells (Burkly et al., 1989; Fink and Bevan,
1978; Jenkins and Schwartz, 1987; Jordan et al., 2000). These
outcomes are dictated by the state of the T cell and/or the biolog-
ical context. In so far as parallels may be drawn, our study offers
genetic evidence that Btnl1 drives Vg7+ IEL selection and cell
biological evidence that Btnl1 and Btnl6 can promote weak acti-
vation of Vg7+ IELs, which was likewise true for human BTNL3
plus BTNL8 interactions with mature gut gd cells. These different
contexts might explain a seeming paradox that CD122 is upre-
gulated by Btnl1-mediated selection in vivo, in common with
agonist selection of thymocytes (Hanke et al., 1994), and yet is
downregulated by Btnl1 plus Btnl6-mediated cell activation
ex vivo, in common with conventional T cell activation (Yu and
Malek, 2001).
Weak activation of mature IEL may reflect the use by epithelia
of site-specific Btnl/BTNL molecules to sustain cognate IELs,
orienting them as to their correct anatomical location and to
the status of the tissue. Consistent with this, Skint1 constitutively
engages Vg5+ DETCs (our unpublished data); Btnl1 can directly
appose IEL at steady state (Bas et al., 2011), and the same may
be true for BTNL3 and BTNL8 in humans, given RNAscope evi-
dence that human colonic gd cells are largely intraepithelial
(our unpublished data). Such findings emphasize intimate and
specific relationships between resting epithelial cells and neigh-
boring T cells that provide a basis for tissue surveillance.
Although gd IELsmake essential contributions to body surface
integrity (Hayday, 2000; Komano et al., 1995; Vantourout andHayday, 2013), our identification of Btnl/BTNL proteins as
key IEL regulators offers to clarify the contexts in which those
contributions are most important. For example, when during
gut development, dysregulation, and/or repair might epithelial
Btnl/BTNL proteins and/or co-factors communicate a need for
IEL activation? Such insight can inform genome-wide associa-
tion study (GWAS) data implicating BTNL/BTN polymorphisms
in numerous immunopathologies (Prescott et al., 2015; Rhodes
et al., 2016; Valentonyte et al., 2005) and may reveal why
epithelia use organ-specific, as opposed to pan-epithelial, Btnl
gene products to regulate local T cells. In fact, different gd
TCRs offer IELs ameans by which to discriminate organ-specific
epithelia that is not obviously available to innate lymphoid cells.
Our and others’ studies have by now implicated Btnl1, Btnl6,
Skint1, BTNL3, BTNL8, BTN3A1, and BTN3A2 in gd cell regula-
tion. Nonetheless, theymay be pleiotropic. For example, the long
cytoplasmic tails of BTNL3, BTNL8, Btnl1, and Btnl6 may signal
back to the cells that display them, consistent with our finding
that Btnl1 attenuates epithelial cell sensitivity to IEL-derived cy-
tokines (Bas et al., 2011). Yet, other BTNL/BTN protein functions
may not relate to gd cell biology (Rhodes et al., 2016), consistent
with which we show that Btnl4 is not critical for gut gd T cell
development. A similar diversity of immunological functions
may describe avian Btnl-like B-G genes, a subset of which
may shape and/or regulate large gd cell compartments in birds
(Kaufman et al., 1999).
A clear exception to the many parallels of Btnl1-mediated IEL
selection and Skint1-mediated DETC selection is Skint1 expres-
sion by thymic epithelial cells (Boyden et al., 2008). Conversely,
the restriction of Btnl1 to the intestine, both naturally and in villin-
driven BiTg mice, clearly establishes that the signature gut IEL
compartment is shaped extrathymically, even if progenitors are
thymus derived, thus resolving a long-standing controversy (Le-
franc¸ois, 1991; Poussier and Julius, 1994). This thymic indepen-
dence may reflect a need to replenish gut IELs so as to maintain
gut integrity post-thymic involution.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Wild-type (WT) C57Bl/6 mice were obtained from Charles River and Harlan. 3 independently derived embryonic stem (e.s.) cells for
Btnl1/ (Btnl1tm1(KOMP)Mbp) and e.s. cells for Btnl4/ (Btnl4tm1(KOMP)Mbp) mice were obtained from the international mouse pheno-
typing consortium (IMPC) (project IDs: CSD67994 and CSD81524). Btnl1indel/indel mice were generated using CrisprCas Technology.
Briefly: Two independent short guide RNAs, targeting the intronic region: between exon1 and 2 and between exon 5 and 6were iden-
tified using the online tool: http://crispr.mit.edu/.
Intron1/2: CCAGCTCCAAGATCCCCCTTGGG Intron5/6: TCCATAGCACCTTATCCGGTTGG
The sg RNAs &PAMsequenceswere cloned into the g-RNA basic vector, translated in vitro, purified and co-injected with Cas9 into
day 1 zygotes and transferred into pseudopregnant foster mice.
WT and Btnl-knockout lines were generated and maintained at The Francis Crick Institute’s Biological resource facilities. B6.Cg-
Foxn1 < Nu > /J (NU/NU) mice were obtained from the Jackson Laboratory. Nur77.gfp mice were kindly provided by K. Hogquist
(Moran et al., 2011). For timed pregnancies, mice weremated overnight and E0was considered as the day a vaginal plug is observed.
Bothmale and femalemice aged between 1 and 35weeks (as indicated) were used in this study. No gender-specific differences were
observed.
Germ-free Mice and Food Antigen-free Nutrition
C57Bl/6 mice maintained on germ-free or on solid-food antigen-free diets were bred at the Institute for Medical Microbiology and
Hospital Epidemiology, University of Marburg, Germanywhere all experiments were conducted according to the German animal pro-
tection law.
Germ-free (GF) mice were kept in plastic isolators (Metall and Plastik, Germany) with autoclaved food, bedding and water. Sterility
of animals was checked bi-weekly by culturing faeces in thioglycollate medium under aerobic and anaerobic conditions for at least
ten days. All handling procedures for GF mice were conducted in a laminar flow hood under sterile conditions. All experiments were
conducted according to the German animal protection law.
Food antigen-free (FAF) mice were raised on an amino acid-containing diet for up to five generations. Pellets of FAF diet (ssniff,
S7242-E014/-E714) contained all essential vitamins, minerals, trace elements, fat, dextrin, sucrose and free amino acids equimolar
to the protein content of normal rodent chow (LASQCdietRod16, LASvendi).
Generation of Doxycycline Inducible Btnl-1 Transgenic Mice
Doxycycline (Dox)-inducible Btnl1-Tg mice were generated by injection of Btnl1/ blastocysts with a linearized cassette
containing a TRE/CMV-promoter upstream of the Btnl1-ORF. The TRE/CMV cassette has been previously described (Op-
penheim et al., 2005). R26-rtTA2-M2 (Hochedlinger et al., 2005) or Villin-rtTA2-M2 (Roth et al., 2009) mice were bred to
homozygosity for Btnl1-deficiency and backcrossed onto Btnl-Tg mice for 3 generations to facilitate global (R26) or local
(Villin) induction of Btnl1 transgene expression by doxycycline administered to drinking water (1mg/ml Dox, 2% suchrose).e4 Cell 167, 203–218.e1–e8, September 22, 2016
Animal experiments were undertaken in full compliance with UK Home Office regulations and under a project license to
A.H. (80/2480).
Flow Cytometry
Flow cytometry was performed using the following antibodies, coupled to the indicated fluorochromes (see key resources table).
Antibodies for mouse: CD3 APC Cy7 (17A2); CD3 PerCPCy5.5 (145-2C11); TCRb Brilliant Violet 421 (H57-597); TCRb APC (H57-
597); CD122 PE (TMb1); CD122 Brilliant Violet 421 (TMb1); CD122 APC (TMb1); TIGIT PE (GIGD7); CD45RB APC Cy7 (C363-16A);
Thy1.2 Brilliant Violet 510 (53-2.1); Lag3 PerCP-efluor 710 (C9B7W); CD5 PE (53-7.3); CD24 FITC (M1/69); CD24 PECy7 (M1/69);
CD8a PECy7 (53-6.7); CD8a PECy7 (53-6.7); TCR Vd4 FITC (GL-2); TCR Vd4 PE (GL-2); CD8b PerCpCy5.5 (YTS156.7.7); CD25
PerCpCy5.5 (PC61); CD69 PECy7 (H1.2F3); CCR9 PECy7 (CW-1.2); CD44 PECy7 (IM7); TCRVg7 (F2.67) was provided by Pablo
Pereira (Institut Pasteur, Paris, France); TCRVg1 APC (2.11); TCRVg4 APC (UC3-10A6); TCRd BV421 (GL3); Ki67 FITC (B56/
MOPC-21); CD45 Qdot 605 (30-F11); CD5 Brilliant Violet 510 (53-7.3); TCRd PeCy7 (GL3); CD161/NK1.1 Brilliant Violet 650
(PK136); CD4 Brilliant Violet 786 (GK1.5); CD8a AlexaFluor 700 (53-6.7); CD25 APC (PC61); GITR PE (DTA-1); CD44 FITC (IM7);
CD62L PerCP-Cy5.5 (MEL-14); KLRG1 BV421 (2F1); CD11c BV786 (HL3); CD11b BV510 (M1/70); F4/80 PerCPCy5.5 (BM8);
Ly6G APC (1A8); Ly6C AlexaFluor 700 (AL-21); CD103 PE (M290); CD317 Brilliant Violet 650 (927); MHCII/IA/IE FITC (2G9);
CD86 Pe-Cy7 (GL1); CD3 Brilliant Violet 421 (145-2C11); CD19 Brilliant Violet 421 (1D3); CD161/NK1.1 (lin) Brilliant Violet
421 (PK136); IgG1 PE (A85-1); B220 (CD45R) AlexaFluor 700 (RA3-6B2); IgM Brilliant Violet 786 (R6-60.2); IgD PerCPCy5.5
(11-26c.2a); GL-7 AlexaFluor 647 (GL7); CD95 PECy7 (Jo2); CD138 Brilliant Violet 650 (281-2); CD21/35 FITC (7G6); CD23 Brilliant
Violet 421 (B-ly6). Antibodies for human: CD25 Brilliant Violet 421 (BC96); CD25 PE (BC96); CD3 Brilliant Violet 510 (OKT3); CD3
BUV (UCHT 1); EpCAM eFlour 660 (1B7); Streptavidin APC-Cy7; Streptavidin Brilliant Violet 421; TCRgd PeCy7 (IMMU510); Vg9
PC5 (IMMU360); Vg9 PE (B3); Vd1 APC (REA173); Vd2 PerCP (B6); Vg2/3/4 biotin (23D12), Vg3/5 biotin (56.3) and Vg8 biotin
(R4.5.1) were provided by D. Kabelitz and D. Wesch (University of Kiel). Other antibodies: DYKDDDDK-PE (Flag); DYKDDDDK-
APC (Flag); HA-DyLight 650; 6x-Histidine-PE.
Commercial antibodies were purchased from Biolegend, eBioscience, BD-Bioscience, Thermo Fisher Scientific or Miltenyi
(see key resource Information). Viability dyes (near IR or Blue) were from Invitrogen. Anti TCRVg7 (F2.67) was purified from hy-
bridoma supernatant using the mouse TCS purification system (Abcam) and conjugated to biotin or AF647 (see key resources
table).
Ki-67 staining was performed on cells fixed and permeabilised using the Foxp3 staining buffer set (eBioscience). BrdU (Sigma-Al-
drich) and EdU incorporation was assessed 3h post-intraperitoneal injection (50mg/kg) by immunohistochemistry or by flow cytom-
etry (Click-iT EdU AF647 Assay Kit, Invitrogen), respectively.
Anti-TCRVg7 (F2.67, provided by Pablo Pereira [Insitut Pasteur, Paris, France]) was purified from hybridoma supernatant using the
mouse TCS purification system (abcam-ab128749). Purified anti-TCRVg7 was conjugated to biotin (EZ-Link Sulfo-NHS-LC Bio-
tinylation Kit, Thermo Fisher Scientific) or to AF647 (labeling kit, Thermo Fisher Scientific). Anti-human Vg2/3/4 (23D12, biotinylated),
Vg5/3 (56.3, biotinylated) and Vg8 (R4.5.1, biotinylated) were provided by D. Kabelitz & D.Wesch (Institute of Immunology, Kiel,
Germany).
Flow cytometry data analysis was performed on FlowJo (Version 9.9).
Plasmids, Cloning, RT-PCR, Transfection and Lentiviral Transduction
The self-inactivating lentiviral vector pCSIGPW (SFFV promoter – Multiple Cloning Site [MCS] – IRES-GFP – CMV promoter – Puro-
mycinR) was constructed by replacing the PuromycinR/mIR cassette from the pAPM vector (Pertel et al., 2011) by a custom EcoRI-
XhoI-PmeI-NotI-BamHI-XbaI-MluI MCS. The IRES-GFP cassette was cloned by PCR from the pIRES2-eGFP vector (Clonetech) us-
ing the BamHI/XbaI sites. The CMV promoter was cloned by PCR from the pCDNA3.1+ vector (Thermo Fischer Scientific) using the
MluI/ClaI sites. The Puromycin resistance genewas cloned by PCR from the pGIPZ vector (Dharmacon) using the ClaI/AgeI sites. The
pCSIGHW variant was generated by exchanging the puromycin resistance gene with a hygromycin B resistance gene, which was
cloned by PCR from the pLHCX vector (Clontech).
cDNAs were (sub-)cloned into pCSIGPW or variant vectors (see Supplemental Information). Btnl1, Btnl4 and Btnl6 were pre-
viously described (Bas et al., 2011). BTNL3 (GenBank:NM_197975.2), BTNL8S (GenBank:NM_024850), and BTNL8 (Gen-
Bank:NM_001040462) were cloned from Caco-2 cells by conventional RT-PCR, using the following primers (See Table S2):
BTNL3 For 50-GAATATCCATGGCTTTTGTGC-30
BTNL3 Rev 50-GTCTTCTCTGTCTCATCCCC-30
BTNL8 For 50-CCATTCACAGAACACATCCATG-30
BTNL8S Rev 50-TATGGGTTACAGTTTTCAGATCAG-30
BTNL8 Rev 50-GTGGGATGTGATTCATCCTAC-30
FLAG, HA andHIS tagswere added downstream of the putative leader peptides by overlapping PCR. Human full-length TCR g and
d chains were cloned (XhoI / NotI, pCSIGPW) using the following primers (See Table S2):
Vg2/3/4 For 50-ATGCAGTGGGCCCTAGCG-30
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Vg9 For 50-ATGCTGTCACTGCTCCACACATC-30
Cg1/2 Rev 50-TTATGATTTCTCTCCATTGCAGCA G-30
Vd1 For 50-ATGCTGTTCTCCAGCCTGCTG-30
Vd2 For 50-ATGCAGAGGATCTCCTCCCTCAT-30
Vd3 For 50-ATGATTCTTACTGTGGGCTTTAGCTTTTTG-30
Cd Rev 50-TTACAAGAAAAATAACTTGGCAGTCAAGAG-30
Expression of BTNL3 and BTNL8 was checked by conventional RT-PCR using the primers indicated above. BTN3A1, BTN3A2,
EPCAM and GAPDH were used as control genes (See Table S2):
BTN3A1 For 50-AGTATCTCCTGATATGCAGCATG-30
BTN3A1 Rev 50-GGAGGAACTCTCTTCTTCTTTTCAC-30
BTN3A2 For 50-TGGTATCTCTTGATATGCAGCATAG-30
BTN3A2 Rev 50-AGAGCATCAGGCTGACTTATTGG-30
EPCAM For 50-GCCGCCACCATGGCGCCCCCGCAG-30
EPCAM Rev 50-TTATGCATTGAGTTCCCTATGCA-30
GAPDH For 50-GAAGGTGAAGGTCGGAGTC-30
GAPDH Rev 50-GAAGATGGTGATGGGATTTC-30
Transfections were carried out in HEK293T cells using PEI (3:1 PEI:DNA ratio, Polysciences). Btnl/BTNL expression was checked
48h post-transfection. Lentiviral particles were produced in HEK293T cells by co-transfection of pCSIGPW or pCSIGHW either
empty or containing Btnl/BTNL cDNAs, pCMVDR8.91 (HIV-1 tat/rev/gag/pol) (Zufferey et al., 1997), and pHIT/G (MLV env) (Fouchier
et al., 1997). Transduced cells were treated with puromycin and hygromycin 48h post-transduction for 7 days, sorted on the basis of
GFP expression and used for functional assays.
Quantitative RT–PCR
Samples were stored in RNAlater (Ambion) or directly frozen in RLT buffer prior to RNA purification (QIAGEN RNeasy kit). cDNA was
generated using Superscript-II (Invitrogen) and analyzed using Sybr-green assay (Invitrogen) using a ViiA7 Real-time PCR machine
(Applied Biosystems) (See Table S2).
Primers for Murine qPCR
Btnl1 For: 50-TGACCAGGAGAAATCGAAGG-30
Btnl1 Rev: 50-CACCGAGCAGGACCAATAGT-30
Btnl4 For: 50-CATTCTCCTCAGAGACCCACACTA-30
Btnl4 Rev: 50-GAGAGGCCTGAGGGAAGAA-30
Bntl6 For: 50-GCACCTCTCTGGTGAAGGAG-30
Btnl6 Rev: 50-ACCGTCTTCTGGACCTTTGA-30
b-Actin For: 50-CAGCTTCTTTGCAGCTCCTT-30
b-Actin Rev: 50-CACGATGGAGGGGAATACAG-30
Sox-13 For: 50-CTCCAGGCCTTCCCAGAC-30
Sox-13 Rev: 50-CATGGACTTCCAGCGAGAAC-30
Rorgc For: 50-GGTGACCAGCTACCAGAGGA-30
Rorgc Rev: 50-CCACATACTGAATGGCCTCA-30
Tbp For: 50-GGGGAGCTGTGATGTGAAGT-30
Tbp Rev: 50-CCAGGAAATAATTCTGGCTCA-30
CycloFor: 50-CAAATGCTGGACCAAACACAA-30
Cyclo Rev: 50-CCATCCAGCCATTCAGTCTTG-30Southern Blotting
Southern blots were performed with probes generated using a Dig-Probe labeling kit; blots were hybridized in DIG-Easy-hyb
buffer overnight, and developed using the DIG-Luminescence Detection Kit (Sigma-Aldrich). For probe sequences
see Supplementary Information. DIG labeled probes for Southern blotting were generated using the following primers
(See Table S2):
Btnl1 For: 50-ACTGGCTTCCTCAGAGTCAT-30
Btnl1 Rev: 50-CAGTAGTGAATGGCCCCTGA-30
Btnl4 For: 50-GACCAACGCTTCCCTACCTC-30
Btnl4 Rev: 50-GCCTTGGGTCCAACAAGACA-30
Btnl1-Tg-Ex3-For: 50-GGTTTTCTGTGAAGGGACCA-30
Btnl1-Tg-Ex4-Rev: 50-GGTCTGCAACTCAGAGGAGG-30e6 Cell 167, 203–218.e1–e8, September 22, 2016
RNAscope
RNAscope was performed on paraffin embedded sections using probes and kits obtained from Advanced Cell Diagnostics using the
RNAscope 2.0 HD Reagent Kit-BROWN. Reference sequences are as follows: Btnl1, GenBank:NM_001111094.1 (576-1723); Btnl4,
GenBank:NM030746.1 (560-968); Btnl6, GenBank:NM_030747.1 (245-1552) (See Table S2).
Isolation of Murine Intestinal Intra-epithelial Lymphocytes (IEL)
IEL were isolated frommouse small intestine as previously described (Wencker et al., 2014). Small intestine was opened and washed
in PBS, cut into 1cm pieces and incubated for 20min in RPMI 1640 supplemented with 1% penicillin/streptomycin (pen/strep), 10%
fetal calf serum (FCS) and 1mM dithiothreitol on a turning wheel. Tissues were washed and vortexed in RPMI, then passed through a
70 mm nylon cell strainer twice, and centrifuged on a 20/40/80% Percoll density gradient at 700 g for 30min. IEL were harvested from
the 40 to 80% Percoll interface.
Spleen and Mesenteric Lymph Node Immunophenotyping
Comprehensive immunophenotyping of Btnl1-/- mice was performed using a platform developed by the Wellcome Trust Infection
and Immunity Immunophenotyping (3i) consortium (www.immunophenotyping.org). In brief, Spleen and MLN were digested with
collagenase (1mg/ml)/DNAse (0.1 mg/ml) in 2% FCS PBS (+ Ca/Mg) for 20 minutes at 37C and filtered through 30mm cell strainers.
Cells were plated on 96 well V-bottom plates, washed in PBS and stained with Zombie Near-IR (Biolegend) for live/dead discrimina-
tion. Antibody stains were performed at 4C for 20mins. Full details regarding phenotyping panels are included in Table S3. Samples
were acquired on a BD LSR Fortessa X-20 equipped with 405nm (40mW), 488nm (50mW), 561nm (50mW), and 640nm (100mW)
lasers.
MODE-K Co-culture Assays
Cells were co-cultured in RPMI 1640 supplemented with 10% FCS, Pen/Strep, 2.5% HEPES, 1% Glutamine, 1% non-essential
amino acids, 1% sodium pyruvate, 0.2% b-mercapto-ethanol (GIBCO) and cytokines including IL-2 (10U/ml), IL-15 (10 ng/ml) (Im-
munotools), IL-3 (100U/ml), IL-4 (200U/ml) (R&D). 105MODE-Kwere seeded in 48-well plates 24h prior to the addition of 105 unsorted
or (where indicated) positively FACS-sorted (CD45+Vg7+) IEL and incubated for 16-18h in 10% CO2 unless indicated otherwise. For
transwell assays, 2x105 MODE-K cells were seeded onto 24-well transwell plates (3 mm pore size - Corning) 24h prior to the addition
of 3x105 IEL, either in direct contact (below), sequestered from (above), or split 50:50 with MODE-K cells (above and below the
transwell).
IEL Stimulation
96-well U bottom plates were coated overnight with 10 mg/ml LEAF-Purified anti-mouse CD3-ε or Hamster IgG Isotype control (Bio-
legend) at 4C andwashed once with PBS 1x before seeding IEL. 100,000 IEL were seeded per well. Cells were incubated at 37C for
16-18h in 10% CO2 prior to analysis.
Confocal Imaging
Proximal small intestine (SI) samples were fixed in Zamboni’s fixative, blocked with normal goat serum and stained with antibodies
against TCRb, TCRd, TCRVd4 (encoded by TRDV2-2) (GL2), CD3 and Vg7. Z-Sections were acquired on a confocal-LSM-710 micro-
scope (Zeiss) and processed and analyzed using Imaris Software (Bitplane Scientific Solutions).
Bone Marrow Chimeras and Adoptive IEL Transfers
10-12 week old recipient mice were irradiated with 950Rads 24h, injected (IV) with 5-10x106 donor bone marrow cells and analyzed
4-12 weeks later.
IEL harvested from 4week-oldWTmice were column-purified using CD45microbeads (MACSMiltenyi biotec) and IV-injected into
6 week-old TCRd/ and TCRd/Btnl1/ recipients. Analysis was performed 2-3 weeks later.
RNA Sequencing
Vg7+CD122hi and Vg7+CD122lo IEL were sorted from from pooled D14-17 pups directly into RLT buffer. RNAwas prepared using the
RNA-Micro-plus kit (QIAGEN). RNA libraries were generated using the KAPA Stranded RNA-seq Kit with RiboErase (HMR) (KAPA
BIOSYSTEMS). Paired-end sequencing on HiSeq 2500 (illumina) using rapid run chemistry (read length: 100bp).
Human Samples and Primary Lymphocyte Isolation
Endoscopic biopsies were obtained from the ascending colon of adult donors undergoing routine diagnostic colonoscopy after
informed consent and in compliance with local ethical approval (REC number 07/H0803/237). Excess resected skin discarded at
the time of cutaneous or reconstructive surgery was obtained from adult donors after informed consent and in compliance with local
ethical approval (REC number 06/Q0704/18). This study was conducted adhering to the principles of the Declaration of Helsinki.
Primary gut lymphocytes were obtained using an adaptation of the method of Kupper and Clarke (Clark et al., 2006) (Figure S7F).
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(Cytomatrix PTY Ltd), were autoclaved and incubated in 100mg/mL rat tail collagen I (BD Biosciences) in PBS for 30min at 37C, and
washed twice in PBS. In compliance with local ethical approval, 12 endoscopic biopsies were taken from the ascending colon of
donors. Biopsies werewashed for 20min in 5mLwashmedium (RPMI 1640 10%FCS, b-mercaptoethanol, penicillin [500U/ml], strep-
tomycin [500 mg/ml], metronidazole [5 mg/ml, Pharmacy department, Guy’s Hospital], gentamicin [100 mg/ml, Sigma-Aldrich] and
amphotericin 12.5 mg/ml [Thermo Fisher Scientific]). One endoscopic biopsy was placed on top of each matrix, which was inverted,
and pressure applied, to crush the biopsy into the matrix. The matrices were placed into a 24-well plate (1 per well) and covered with
2mL RPMI 1640 (supplemented with 10% FCS, b-mercaptoethanol, penicillin [100U/ml], streptomycin [100 mg/ml], metronidazole
[1 mg/ml], gentamicin [20 mg/ml], amphotericin [2.5 mg/ml]), IL-2 (100U/mL, Novartis Pharmaceutical UK) and IL-15 (10ng/mL, Bio-
legend). 1ml of mediumwas aspirated every second day and replacedwith completemedium containing 2x concentrated cytokines.
Cells were harvested and residual biopsy and empty wells were washed with PBS 0.02mMHEPES. The cell suspension was passed
through a 70 mm nylon cell strainer, centrifuged at 400 g for 5min and resuspended in complete medium without additional cytokine
and placed into co-culture immediately. Lymphocytes were used after 5-7 days of culture.
PBMC were isolated by Ficoll gradient from blood obtained from the blood donation service.
Human Epithelial Cell Isolation
Colonic samples were incubated with 5 mM 1,4-dithiothreitol (Sigma), followed by enzymatic digestion with 1.5mg/ml collagenase
VIII (Sigma) and 0.05 mg/mL DNase I (Sigma). EpCAM+ cells were sorted by flow cytometry directly into RLT lysis buffer. RNA and
cDNA were prepared as described above.
HEK293T Co-culture Assay
5x105 HEK293T cells, transduced with either empty vector (EV), BTNL3, BTNL8 or BTNL3+8 and 2x105 freshly harvested primary
human lymphocytes were co-cultured in 96-well plates with complete medium (see Supplementary Information) without supplemen-
tary cytokine and incubated at 37C at 5% CO2 for 16hrs (Figure S7F).
Deep Sequencing
Mouse TRDV gene: Amplification and sequencing of TCRd CDR3 from RNA purified from sorted Vg7+ IEL was performed using the
Amp2Seq Platform (iRepertoire).Human TCRG Vg gene: Amplification and sequencing of TCRg CDR3 was performed using the im-
munoSEQ Platform (Adaptive Biotechnologies).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics
Unless stated otherwise, bar/spider charts display mean ± SD and p values were derived from unpaired two tailed t tests, assuming
equivalent SD (ns > 0.05).
Imaris Image Analysis
Confocal microscopy was performed using a LSM710 laser scanning confocal microscope (Zeiss) with a 40x oil objective (numerical
aperture 1.3). 3D image analysis on z-stackswas carried out using Imaris (Bitplane). The surfaces tool was used to identify CD3+ cells.
Voxels outside of these structures were set to zero in each of the channels to create masks.
Bioinformatics Analysis of RNA Sequencing
101 base-pair paired-end reads were aligned and quantified using RSEM (v1.2.11) (Li and Dewey, 2011) with Bowtie2. Reads were
aligned to a transcriptome constructed from the mm10 mouse genome and a UCSC knownGene gtf file. A mean alignment rate of
57.4 million fragments per sample was observed. Using the gene level quantification, only detected genes (mean TPM value across
all samples > 1; 13,313 genes) were selected. Differential expression between the CD122hi and CD122lo Vg7+ IEL groups using DE-
Seq2 (Love et al., 2014) was identified by taking into account the paired structure within the replicate groups. Using an FDR of 0.01
2664 phenotype dependent gene expression effects were identified.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the RNA sequencing data reported in this paper is GEO: GSE85422.e8 Cell 167, 203–218.e1–e8, September 22, 2016
Supplemental Figures
Figure S1. Phenotypic Differences between CD122HI Vg7+ IELs and Other IEL Subsets, Related to Figure 1
(A) Cell surface phenotype of Vg7+, Vg7- (CD3+TCRb-Vg7-) and ab (TCRb+) IEL from 3-5 week old (W3-5) C57Bl/6 (WT) mice (nR 7). (B) Cell surface phenotype of
WT Vg7+CD122HI versus Vg7+CD122LO IEL (nR 7). (C) Heat map of genes differentially expressed (log-2-FoldChange) between Vg7+CD122hi and Vg7+CD122lo
IEL sorted from D14-D17 WT mice. Data generated by RNA sequencing (‘cell cycle’ & ‘cell surface’ GO terms annotated). Values scaled to their median value
across the samples. (D) 3hr EdU incorporation in vivo in Vg7+ versus Vg7- IEL from D28 WT mice assessed by flow cytometry in indicated IEL subsets (Vg7- are
CD3+TCRb-Vg7-). Data are representative of 1 (C) orR 3 (A,B) independent experiments. Panel (D) presents data pooled from 3 independent experiments. All
error bars represent mean ± SD. Related to Figure 1.
(legend on next page)
Figure S2. Local Intestinal Development of CD122HI Vg7+ IELs, Related to Figure 2
(A) Deep sequencing of TCR Vd chain usage in WT Vg7+ IEL sorted from W7-10 C57Bl/6 (WT) mice (n = 3). (B) Absolute numbers of WT Vg7+ and Vg7+GL2+
thymocytes from WT mice assessed by flow cytometry. C-D) Cell surface phenotype of WT Vg7+ IEL and thymocytes at indicated time points. (E) Cell surface
phenotype of Vg7+ thymocytes and IEL isolated from W3-5 WT mice (n = 5). (F) gd IEL composition (left), cell count (middle) and cell surface CD122 expression
(right) in WT versus alymphoplasia (aly/aly) mice. (G) Longitudinal RNAscope analysis of Btnl1 expression during gut development. (H) Gene expression by
qRT.PCR along the length of the gut in WT mice (nR 3). (I) Gene expression by qRT.PCR in the thymus of WT and Btnl1/ animals compared to the proximal
small intestine. (J) Organization of WT and targeted loci for Btnl1/, Btnl1indel/indel and Btnl4/ mice. Grey: untranslated region; green: translated region;
orange: inserted targeting cassette. Knockout ES cell cloneswere obtained from the internationalmouse consortium IKMC-ID 67994 (Btnl1) and 81524 (Btnl4). (K)
Southern blot for targeting of alleles inBtnl1/ andBtnl4/mice. Genomic DNAwas digested using the indicated enzymes (arrowheads). Probes targeting the
indicated regions were generated to detect the WT and targeted alleles. Data are representative ofR 1 (A,K) orR 2 (C,E,G,H,I) independent experiments. Some
panels include data pooled from 2 (F), > 3 (D) or > 6 (B) independent experiments. All error bars represent mean ± SD. Related to Figure 2
(legend on next page)
Figure S3. Btnl1 Has No Detectable Effect on the Systemic T, B, and Myeloid Cell Compartments, Related to Figure 3
(A) gd IEL composition in adult WT versus Btnl1indel/indel mice (n = 3) (B) Mesenteric Lymph Node (MLN) and (C) Splenic immune compartments of WT, Btnl1+/
and Btnl1/ analyzed by flow cytometry (n = 7–9). (D) TCRVg chain usage in MLN and splenic lymphocytes harvested from WT, Btnl1+/ and Btnl1/mice
assessed by flow cytometry (n = 8). (E) Vg7+ and Vg7+GL2+ thymocytes from WT or Btnl1+/ and Btnl1/mice assayed by flow cytometry to enumerate total
cell counts (left) and cell surface phenotype (right) at three time points. Panels (A-D) are representative of 1 experiment. Panel E-left presents data pooled fromR 2
independent experiments. All error bars represent mean ± SD. See Table S3.
Figure S4. Impact of Btnl1 on Intestinal Engraftment, Expansion, and Retention of CD122HI Vg7+ IELs, Related to Figure 4
(A) Ki67+ expression in Vg7+ IEL isolated from WT versus Btnl1/mice (n = 4-27). (B) Cell surface phenotype of Btnl1/ Vg7+CD122HI versus Vg7+CD122LO
and Vg7+GL2+CD122HI versus Vg7+GL2+CD122LO IEL displayed in Figure 4B (nR 8). (C) Irradiated TCRdKOmice reconstituted withWT bonemarrow (BM) were
analyzed for gd IEL composition at the indicated time-points after BM transfer (nR 3). (D) IEL isolated from WT W4-5 mice were column-purified using CD45
microbeads and adoptively transferred intravenously into W6 TCRd/ or TCRd/Btnl1/ hosts. gd T cell composition was assayed 2-3 weeks later by flow
cytometry (nR 5). Data are representative of 1 (C), 2 (D) orR 3 (B) independent experiments. Bar graph displays mean ± SD. All error bars represent mean ± SD.
Figure S5. Inducible Btnl1 Transgene Expression and Its Impact in Adult Mice, Related to Figure 5
(A) Schematic representation of the WT Btnl1 locus (top) and TRE-Btnl1 transgene construct (bottom). Grey: unstranslated region; green: translated region;
orange: upstream-tetracycline response element/CMV promoter and downstream-b-globulin/polyA. (B) Southern blot to detect transgene insertion. Genomic
DNAwas digestedwith EcoR1 as indicated (arrowheads) and a probe (blue bar) targeting the indicated region (Exon3/4 boundary inORF) was generated to detect
the WT and targeted allele (n = 2). C-F) W7-13 (ADULT) mice of indicated genotypes on a Btnl1/ background were administered doxycycline water (1mg/ml
Dox, 2% suchrose) or ctrl water (2% suchrose) for 1-2 weeks. (C) Gene expression by qRT.PCR in proximal small intestine of adult mice following the indicated
treatment. (D) gdIEL composition (left) and absolute cell counts (right) assessed by flow cytometry in adult mice following the indicated treatment (sugar, n = 3-5;
rest, n = 4-10). (E) Ki67 and cell surface CD122 expression in Vg7+ IEL from adult mice following the indicated treatment. (F) Ki67 expression in Vg7+ versus Vg7-
and TCRb+ IEL from adult mice following the indicated treatment (n = 5-9). Data are representative of 2 (B), or 3 independent experiments. Some panels include
results pooled from 2 (C) orR 3 (D,F) independent experiments. All error bars represent mean ± SD.
Figure S6. Co-expression of Btnl1 and Btnl6 and Their Impact on Vg7+ IELs, Related to Figure 6
(A) Cell surface expression of FLAG-Btnl1, HIS-Btnl4 or HA-Btnl6 co-transfected in MODE-K cells. Histogram overlays show the expression of each BTNL after
gating on GFP+ cells (numbers in brackets indicate geometric mean fluorescence intensity, gMFI). (B) Primary small intestinal IEL cultured for the indicated times
with MODE-K cells transduced with constructs expressing an empty vector (EV) versus Btnl1+Btnl6 (L1+6) (n = 7). (C) Representative plots of cell surface CD122
and CD25 expression on Vg7+ cells after the indicated overnight culture conditions (n = 21). (D) Cell surface CD25 expression in positively FACS-sorted Vg7+ IEL
after overnight co-culture with MODE-K cells expressing EV versus L1+6 (n = 4). (E) Cell surface CD25 expression in primary Vg7+ IEL after overnight co-culture
with the indicated MODE-K transductants in the presence PP2, PP3 or vehicle. Data are representative of representative of 2 (A,D), or > 5 (C) independent
experiments. Some panels (B,E) present data pooled from 2 independent experiments. All error bars represent mean ± SD.
Figure S7. Human Intestinal gd Cells and the Selective Impact on Them of BTNL3 and BTNL8 Co-expression, Related to Figure 7
(A) FACS-sorted gd T cells harvested from human intestinal tissue were analyzed by deep sequencing for TCR Vg chain usage. (B) Schematic illustrating the
murine and human Btnl2/BTNL2 and Btnl9/BTNL9 loci, adapted from the NCBI gene viewer. (C) Conventional RT-PCR analysis of BTN3A2, BTNL3 and BTNL8
expression in the indicated tissues. (D) Conventional RT-PCR analysis of BTN3A1, BTNL3, BTNL8, EPCAM and TCR Vg2/3/4 expression in the indicated
samples. (E) Cell surface expression of FLAG-BTNL3, FLAG-BTNL8S or FLAG-BTNL8 co-transfected in HEK293 cells with the indicated constructs. Histogram
overlays show the expression of eachBTNL after gating onGFP+ cells (numbers in brackets indicate geometricmean fluorescence intensity, gMFI). (F) Schematic
illustrating the method of human intestinal tissue-resident lymphocytes isolation and co-culture with HEK293 transductants. (1) Endoscopic biopsies recovered
from ascending colon of healthy donors. (2) Washed in complete media supplemented with antibiotic. (3) 1 biopsy applied to each matrix. (4) Culture for 5-7 days
in complete medium supplemented with antibiotics, IL-2 and IL-15. (5) Co-culture with HEK293 cell lines transduced with EV, L3, L8 or L3+8. (G) Cell surface
CD25 expression on indicated subsets of human gut-derived lymphocytes after co-culture with EV versus L3+8-transduced HEK293 cells. (H) Gating parameters
for sorting of Btnl3+8-responsive human gut-derived lymphocytes. (I) TCRVg chain usage (left) and cell surface TCRgd expression (right) in gut-derived gd T cells
(isolated from a donor unresponsive to BTNL3+8) after co-culture with EV versus L3+8-transduced HEK293 cells.
